Re: 04-14-10 eSNAP/2590 reporting on parent with ARRA Admin Suppl Award Zoya Hamilton 15 Apr 2010 14:07 EST
Carol Ann, It is my understanding that the progress on the supplement must be described in the scientific narrative. Zoya -- Zoya Hamilton, CRA Sr. Associate Director, Research Administration Office of the Vice Provost Tufts University Tel (617) 636-6709 Fax (617) 636-2917 http://researchadmin.tufts.edu/ Amella, Carol Ann wrote: > > Hi everyone, > > We are getting ready to submit eSNAPS/2590-s for our parent awards who > also have ARRA administrative supplement awards. We know that grantees > need to include specific information on the ARRA additional funding as > part of the annual progress report for the parent grant. > > *For the eSNAP, we are planning to select the type of supplement > support from the ‘Supplement Support drop-down box’ in the _All > Personnel Section_ of the report as directed in the /eSNAP April 12, > 2010 guidelines page 23/. > > *For the 2590, we will indicate the analogous by using the > abbreviations indicated in the /PHS2590 06/2009 guidelines page 24./ > > Is anyone else mentioning the ARRA funds/ARRA progress in the > scientific narrative or anywhere else in these eSNAP/2590 reports? > > Thank you, > > *Carol Ann * > > Carol Ann Amella > Assistant Director > Office of Grants and Contracts > Feinstein Institute for Medical Research > 350 Community Drive > Manhasset, NY 11030 > ph-516-562-3106 > xxxxxx@nshs.edu <mailto:xxxxxx@nshs.edu> > > --------------------------------------------------------------------------------- > > The information contained in this electronic e-mail transmission > > and any attachments are intended only for the use of the individual > > or entity to whom or to which it is addressed, and may contain > > information that is privileged, confidential and exempt from > > disclosure under applicable law. If the reader of this communication > > is not the intended recipient, or the employee or agent responsible > > for delivering this communication to the intended recipient, you > > are hereby notified that any dissemination, distribution, copying > > or disclosure of this communication and any attachment is strictly > > prohibited. If you have received this transmission in error, please > > notify the sender immediately by telephone and electronic mail, > > and delete the original communication and any attachment from any > > computer, server or other electronic recording or storage device > > or medium. Receipt by anyone other than the intended recipient is > > not a waiver of any attorney-client, physician-patient or other > > privilege. Thank you. > > ====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") > ====================================================================== > ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================